Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria - Summary - MDSpire
Advertisement
Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria
To compare serum levels of malondialdehyde, 8-iso-prostaglandin F2α, and lipid profiles between COVID-19 patients and healthy controls in South-Western Nigeria, emphasizing the significance of these findings in understanding the disease's metabolic impacts, particularly in the context of co-infections.
Key Findings:
Elevated levels of malondialdehyde and 8-iso-prostaglandin F2α were observed in COVID-19 patients compared to controls (p < 0.05).
Lipid profiles showed significant alterations, with lower levels of total cholesterol, LDL-C, and HDL-C in severe cases (p < 0.01).
Co-infections, particularly malaria, were associated with increased oxidative stress markers (p < 0.05).
Interpretation:
The findings indicate that COVID-19 is associated with significant oxidative stress and lipid metabolism disturbances, which may contribute to disease severity, particularly in the context of co-infections. This highlights the need for targeted interventions.
Limitations:
The sample size was limited due to recruitment constraints during the pandemic, which may affect the generalizability of the findings.
The study was cross-sectional, limiting causal inferences and the ability to assess long-term effects.
Conclusion:
This study highlights the need for region-specific data on oxidative stress and lipid profiles in COVID-19 patients, particularly in African populations, to better understand the disease's metabolic impacts and inform future research directions.
